Publication | Closed Access

Hepatic stellate cell-targeted imatinib nanomedicine versus conventional imatinib: A novel strategy with potent efficacy in experimental liver fibrosis

Liver FibrosisConventional ImatinibBiomedical EngineeringExperimental Liver FibrosisCirrhosisNanomedicineHepatology FibrosisMatrix BiologyRadiation OncologyHealth SciencesFibrosisNovel StrategyLiver PhysiologyHepatology InflammationCell BiologyTumor MicroenvironmentHepatologyLiver DiseaseLiver CancerMedicine